Analyst Ratings for Nexvet Biopharma (NVET)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2017 | Credit Suisse | N/A | Downgrade | Neutral (Outperform) |
6.72 (8.00) |
6.60 (6.72) |
1.82% | Details |
| 3/10/2015 | TD Cowen » Updated 11/24/2015 |
N/A | New Coverage | Buy (N/A) |
13.00 (N/A) |
10.10 (6.72) |
-33.47% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


